IVIG modulation of chemokines for treatment of multiple sclerosis, Alzheimer's disease, and Parkinson's disease

Details for Australian Patent Application No. 2008286361 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Ehrlich, Hartmut; Schwarz, Hans-Peter; Reipert, Birgit; Elovaara, Irina

Agent Cullens

Pub. Number AU-A-2008286361

PCT Pub. Number WO2009/021708

Priority 60/955,610 13.08.07 US

Filing date 11 August 2008

Wipo publication date 19 February 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/021708 Priority application(s): WO2009/021708

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008286362-Hook coupling

2008286357-Repair of lesions in cartilage and bone using a chondro-regulative matrix